| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aprea Therapeutics, Inc. (APRE) has 10 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. APRE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 259.3K | $205.9K | - | |
| Dir | 48.9K | $38.8K | - | |
| CFO | 27.7K | $22.0K | - | |
| CEO | 21.5K | $17.0K | - | |
| Dir | 13.4K | $10.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 7, 2019 | Korbel Gregory Alan83 | VP Of Business Dev't | Buy | 500 | $15.00 | $7,500.00 | New | |
| Oct 7, 2019 | Healthcap Vii, L.P. | 10% Owner | Buy | 266,667 | $15.00 | $4,000,005.00 | +12.7% | |
| Oct 7, 2019 | Christenson Johan | Director | Buy | 266,667 | $15.00 | $4,000,005.00 | +12.7% | |
| Oct 7, 2019 | Versant V Luxco S.A R.L. | 10% Owner | Buy | 333,333 | $15.00 | $4,999,995.00 | New | |
| Oct 7, 2019 | Versant Vantage I, L.P. | 10% Owner | Buy | 333,333 | $15.00 | $4,999,995.00 | New | |
| Oct 7, 2019 | Redmile Group, LLC | 10% Owner | Buy | 400,000 | $15.00 | $6,000,000.00 | +21.4% | |
| Oct 7, 2019 | Attar Eyal C.85 | SVP, Chief Medical Officer | Buy | 400 | $15.00 | $6,000.00 | New | |
| Oct 7, 2019 | Coiante Scott M | SVP, Chief Financial Officer | Buy | 2,500 | $15.00 | $37,500.00 | New | |
| Oct 7, 2019 | Magni Guido | Director | Buy | 6,500 | $15.00 | $97,500.00 | New |